June 2, 2025

Menopausal Symptom Management in Breast Cancer Survivors — A Promising New Option

New England Journal of Medicine, Ahead of Print.

June 2, 2025

Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

New England Journal of Medicine, Ahead of Print.

June 1, 2025

First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer

New England Journal of Medicine, Ahead of Print.

May 31, 2025

Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer

New England Journal of Medicine, Ahead of Print.

May 20, 2025

(PDF) Breast carcinoma en Cuirasse – Case report – researchgate.net